Caris Life Sciences director granted 13,192 RSUs

HALBERT JON reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

HALBERT JON reported acquisition or exercise transactions in this Form 4 filing.

Caris Life Sciences, Inc. director Jon Halbert reported a grant of 13,192 restricted stock units of common stock on 2026-08-14 at $0.00 per share, vesting under an applicable grant agreement. Following this award, he holds 131,813 shares directly and indirect holdings of 652,062 shares through a family trust and 706,531 shares through LAH Investments, Ltd., where beneficial ownership is disclaimed except for his pecuniary interest.

Insider Trade Summary

Grant/Award: 13,192 shares

Grant/Award 3 txns

Insider HALBERT JON

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	13,192	$0.00	$0.00
holding	Common Stock F2	--	--	--
holding	Common Stock F2, F3	--	--	--

Holdings After Transaction: Common Stock — 131,813 shares (Direct); Common Stock — 652,062 shares (Indirect, By Family Trust); Common Stock — 706,531 shares (Indirect, By LAH Investments, Ltd.)

Footnotes (3)

1. F1. Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.
2. F2. Includes shares received in pro rata distributions exempt pursuant to Rule 16a-9.
3. F3. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Key Figures

RSUs granted: 13,192 shares Grant price per share: $0.00 Direct holdings after grant: 131,813 shares +2 more

5 metrics

RSUs granted 13,192 shares Restricted stock unit award of common stock on 2026-08-14

Grant price per share $0.00 Price per share for the restricted stock unit grant

Direct holdings after grant 131,813 shares Total direct common stock owned after the award

Family trust holdings 652,062 shares Indirect ownership by family trust, including pro rata distributions

LAH Investments holdings 706,531 shares Indirect ownership by LAH Investments, Ltd., with beneficial ownership disclaimed except for pecuniary interest

Key Terms

restricted stock units, pro rata distributions, Rule 16a-9, pecuniary interest, +1 more

5 terms

restricted stock units financial

"Represents an award of restricted stock units which vest in accordance"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

pro rata distributions financial

"Includes shares received in pro rata distributions exempt pursuant"

Rule 16a-9 regulatory

"shares received in pro rata distributions exempt pursuant to Rule 16a-9"

pecuniary interest financial

"disclaims beneficial ownership except to the extent of his pecuniary interest"

beneficial ownership financial

"The Reporting Person disclaims beneficial ownership except to the extent"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CAI director Jon Halbert report on this Form 4?

Jon Halbert reported a grant of 13,192 restricted stock units of Caris Life Sciences, Inc. common stock on 2026-08-14, received at $0.00 per share as equity compensation vesting under an applicable grant agreement.

How many CAI shares does Jon Halbert now hold directly after this award?

After the reported award, Jon Halbert directly holds 131,813 shares of Caris Life Sciences, Inc. common stock. This figure reflects his direct ownership position following the 13,192 restricted stock units grant.

What indirect holdings in CAI stock are associated with Jon Halbert?

Indirectly, interests associated with Jon Halbert include 652,062 shares held by a family trust and 706,531 shares held by LAH Investments, Ltd., including shares received in pro rata distributions exempt under Rule 16a-9.

Does Jon Halbert claim full beneficial ownership of all indirect CAI shares?

No. For the LAH Investments, Ltd. holdings, he disclaims beneficial ownership except to the extent of his pecuniary interest, meaning his economic interest may be less than the full share amount.

Were the CAI restricted stock units granted as a purchase by Jon Halbert?

The 13,192 restricted stock units were reported with code A as a grant or award, not a market purchase. They were received at $0.00 per share as part of an equity compensation arrangement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2026 - 05:38 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HALBERT JON

(Last) (First) (Middle)

C/O CARIS LIFE SCIENCES, INC.

750 W. JOHN CARPENTER FREEWAY, SUITE 800

(Street)

IRVING TEXAS 75039

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Caris Life Sciences, Inc. [ CAI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2026		A		13,192(1)	A	$0	131,813	D
Common Stock								652,062(2)	I	By Family Trust
Common Stock								706,531(2)	I	By LAH Investments, Ltd.(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.

2. Includes shares received in pro rata distributions exempt pursuant to Rule 16a-9.

3. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Remarks:

	/s/ J. Russel Denton, Attorney-in-Fact	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)